Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms
Abstract Background/Objectives: Intraductal papillary mucinous neoplasms (IPMNs) are a
cystic precursor to pancreatic cancer. IPMNs deemed clinically to be at high-risk for …
cystic precursor to pancreatic cancer. IPMNs deemed clinically to be at high-risk for …
Intraductal papillary mucinous neoplasm of the pancreas: Cytomorphology, imaging, molecular profile, and prognosis
B Geramizadeh, M Marzban, A Shojazadeh… - …, 2021 - Wiley Online Library
Background Intraductal papillary mucinous neoplasm (IPMN) constitutes up to 20% of all
pancreatic resections, and has been increasing in recent years. Histomorphological findings …
pancreatic resections, and has been increasing in recent years. Histomorphological findings …
Risk of advanced lesions in patients with branch-duct IPMN and relative indications for surgery according to European evidence-based guidelines
E Pérez-Cuadrado-Robles, L Uribarri-González… - Digestive and Liver …, 2019 - Elsevier
Background European evidence-based guidelines proposed surgery for branch-duct
intraductal papillary mucinous neoplasms (BD-IPMNs) based on the presence of 1–2 …
intraductal papillary mucinous neoplasms (BD-IPMNs) based on the presence of 1–2 …
Efficacy and safety of pancreatic juice cytology with synthetic secretin in diagnosing malignant intraductal papillary mucinous neoplasms of the pancreas
Y Takeda, K Matsumoto, T Onoyama, T Yamashita… - Diagnostics, 2022 - mdpi.com
The risk of malignant transformation of intraductal papillary mucinous neoplasm (IPMN) is
presently assessed using imaging, which remains unsatisfactory. Given the high viscosity of …
presently assessed using imaging, which remains unsatisfactory. Given the high viscosity of …
The efficacy of pancreatic juice cytology with liquid-based cytology for evaluating malignancy in patients with intraductal papillary mucinous neoplasm
K Miyamoto, K Matsumoto, H Kato, R Yoshida… - BMC …, 2020 - Springer
Background Pancreatic juice cytology (PJC) is a tool for diagnosing malignant intraductal
papillary mucinous neoplasm (IPMN); however, the accuracy is insufficient using the …
papillary mucinous neoplasm (IPMN); however, the accuracy is insufficient using the …
Tumor mucinoso papilar intraductal de páncreas: Revisión temática
MBR Sanz, FM Racionero, AA de Benito… - Cirugía …, 2023 - dialnet.unirioja.es
La neoplasia mucinosa papilar intraductal es una lesión descrita en 1980 por Ohashi. Esta
neoplasia ha recibido diversos nombres lo cual contribuyó a la confusión, a su mal …
neoplasia ha recibido diversos nombres lo cual contribuyó a la confusión, a su mal …
Intraductal Papillary Mucinous Neoplasia of the Pancreas-Pathologic Features and Molecular Markers-A Review
MA Cipriano, RC Oliveira - Surgery, Gastroenterology and …, 2019 - estudogeral.uc.pt
Intraductal papillary mucinous neoplasm (IPMN) of the pancreas are pre neoplastic lesions
defined by the World Health Organization as a grossly visible intraductal epithelial neoplasm …
defined by the World Health Organization as a grossly visible intraductal epithelial neoplasm …